{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:09:10Z","timestamp":1793750950495,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["091231"],"award-info":[{"award-number":["091231"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00125-016-4053-x","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T21:25:39Z","timestamp":1469741139000},"page":"2181-2192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial"],"prefix":"10.1007","volume":"59","author":[{"given":"Helen","family":"Vlassara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Pyzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Tansman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish N.","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary E.","family":"Striker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Uribarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"issue":"Suppl 5","key":"4053_CR1","first-page":"S1","volume":"14","author":"AF Amos","year":"1997","unstructured":"Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14(Suppl 5):S1\u2013S85","journal-title":"Diabet Med"},{"key":"4053_CR2","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1161\/CIRCULATIONAHA.106.613828","volume":"113","author":"CS Fox","year":"2006","unstructured":"Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D\u2019Agostino RB Sr (2006) Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation 113:2914\u20132918","journal-title":"Circulation"},{"key":"4053_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","volume":"53","author":"J Jason","year":"2004","unstructured":"Jason J, Laedtke T, Parisis JE, O\u2019Brien P, Petersen RC, Butler PC (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53:474\u2013481","journal-title":"Diabetes"},{"key":"4053_CR4","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.2337\/diacare.27.10.2444","volume":"27","author":"ES Ford","year":"2004","unstructured":"Ford ES, Giles WH, Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27:2444\u20132449","journal-title":"Diabetes Care"},{"key":"4053_CR5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/CIRCULATIONAHA.107.716159","volume":"117","author":"PL Lutsey","year":"2008","unstructured":"Lutsey PL, Steffen LM, Stevens J (2008) Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 117:754\u2013761","journal-title":"Circulation"},{"key":"4053_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860\u2013867","journal-title":"Nature"},{"key":"4053_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2458-14-14","volume":"14","author":"LL Roberson","year":"2014","unstructured":"Roberson LL, Aneni EC, Maziak W et al (2014) Beyond BMI: the \u2018metabolically healthy obese\u2019 phenotype, its association with clinical\/subclinical cardiovascular disease and all-cause mortality\u2014a systematic review. BMC Public Health 14:14","journal-title":"BMC Public Health"},{"key":"4053_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","volume":"1","author":"N Stefan","year":"2013","unstructured":"Stefan N, Haring HU, Hu FB, Schulze MB (2013) Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 1:152\u2013162","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4053_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/oby.20257","volume":"21","author":"AL Hankinson","year":"2013","unstructured":"Hankinson AL, Daviglus ML, Van Horn L et al (2013) Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity (Silver Spring) 21:637\u2013643","journal-title":"Obesity (Silver Spring)"},{"key":"4053_CR10","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.2015.5941","volume":"313","author":"D Mozzafarian","year":"2015","unstructured":"Mozzafarian D, Ludwig D (2015) The 2015 US dietary guidelines: lifting the ban on total dietary fat. JAMA 313:2421\u20132422","journal-title":"JAMA"},{"key":"4053_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.7326\/M13-1788","volume":"160","author":"R Chowdhury","year":"2014","unstructured":"Chowdhury R, Warnakula S, Kunutsor S et al (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 160:398\u2013406","journal-title":"Ann Intern Med"},{"key":"4053_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF03402014","volume":"8","author":"W Cai","year":"2002","unstructured":"Cai W, Gao QD, Zhu L, Peppa M, He C, Vlassara H (2002) Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med 8:337\u2013346","journal-title":"Mol Med"},{"key":"4053_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrendo.2011.74","volume":"7","author":"H Vlassara","year":"2011","unstructured":"Vlassara H, Striker GE (2011) AGE restriction in diabetes mellitus: a paradigm shift. Nat Rev Endocrinol 7:526\u2013539","journal-title":"Nat Rev Endocrinol"},{"key":"4053_CR14","doi-asserted-by":"publisher","first-page":"15888","DOI":"10.1073\/pnas.1205847109","volume":"109","author":"W Cai","year":"2012","unstructured":"Cai W, Ramdas M, Zhu L, Chen X, Striker GE, Vlassara H (2012) Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci U S A 109:15888\u201315893","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4053_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jada.2010.03.018","volume":"110","author":"J Uribarri","year":"2010","unstructured":"Uribarri J, Woodruff S, Goodman S et al (2010) Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 110:911\u2013916","journal-title":"J Am Diet Assoc"},{"key":"4053_CR16","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3945\/ajcn.2009.28737","volume":"91","author":"I Birlouez-Aragon","year":"2010","unstructured":"Birlouez-Aragon I, Saavedra G, Tessier FJ et al (2010) A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr 91:1220\u20131226","journal-title":"Am J Clin Nutr"},{"key":"4053_CR17","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.2337\/dc11-0091","volume":"34","author":"J Uribarri","year":"2011","unstructured":"Uribarri J, Cai W, Ramdas M et al (2011) Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 34:1610\u20131616","journal-title":"Diabetes Care"},{"key":"4053_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2337\/dc13-0842","volume":"37","author":"AB Mark","year":"2014","unstructured":"Mark AB, Poulsen MW, Andersen S et al (2014) Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women. Diabetes Care 37:88\u201395","journal-title":"Diabetes Care"},{"key":"4053_CR19","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1210\/jc.2009-0089","volume":"94","author":"H Vlassara","year":"2009","unstructured":"Vlassara H, Cai W, Goodman S et al (2009) Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab 94:4483\u20134491","journal-title":"J Clin Endocrinol Metab"},{"key":"4053_CR20","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1210\/jc.2014-3925","volume":"100","author":"J Uribarri","year":"2015","unstructured":"Uribarri J, Cai W, Woodward M et al (2015) Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obese? J Clin Endocrinol Metab 100:1957\u20131966","journal-title":"J Clin Endocrinol Metab"},{"key":"4053_CR21","doi-asserted-by":"crossref","unstructured":"NCEP (2002) Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106:3143-3421","DOI":"10.1161\/circ.106.25.3143"},{"key":"4053_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"4053_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/sj.ijo.0803696","volume":"32","author":"S Bonekamp","year":"2008","unstructured":"Bonekamp S, Ghosh P, Crawford S et al (2008) Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging. Int J Obes (Lond) 32:100\u2013111","journal-title":"Int J Obes (Lond)"},{"key":"4053_CR24","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0140-6736(11)61383-4","volume":"378","author":"ZA Fayad","year":"2011","unstructured":"Fayad ZA, Mani V, Woodward M et al (2011) Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 378:1547\u20131559","journal-title":"Lancet"},{"key":"4053_CR25","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1016\/S0021-9258(18)42741-X","volume":"267","author":"Z Makita","year":"1992","unstructured":"Makita Z, Vlassara H, Cerami A, Bucala R (1992) Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133\u20135138","journal-title":"J Biol Chem"},{"key":"4053_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0022-1759(97)00110-5","volume":"207","author":"T Mitsuhashi","year":"1997","unstructured":"Mitsuhashi T, Vlassara H, Founds HW, Li YM (1997) Standardizing the immunological measurement of advanced glycation endproducts using normal human serum. J Immunol Methods 207:79\u201388","journal-title":"J Immunol Methods"},{"key":"4053_CR27","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1073\/pnas.1316013111","volume":"111","author":"W Cai","year":"2014","unstructured":"Cai W, Uribarri J, Zhu L et al (2014) Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci U S A 111:4940\u20134945","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4053_CR28","doi-asserted-by":"publisher","first-page":"E419","DOI":"10.1152\/ajpendo.00417.2009","volume":"298","author":"T Yoshizaki","year":"2010","unstructured":"Yoshizaki T, Schenk S, Imamura T et al (2010) SIRT 1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 298:E419\u2013E428","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4053_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00726-013-1502-4","volume":"46","author":"J Uribarri","year":"2014","unstructured":"Uribarri J, Cai W, Pyzik R et al (2014) Suppression of native defense mechanisms, SIRT1 and PPAR\u03b3, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases. Amino Acids 46:301\u2013309","journal-title":"Amino Acids"},{"key":"4053_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrendo.2009.101","volume":"5","author":"F Liang","year":"2009","unstructured":"Liang F, Kume S, Koya D (2009) SIRT1 and insulin resistance. Nat Rev Endocrinol 5:367\u2013373","journal-title":"Nat Rev Endocrinol"},{"key":"4053_CR31","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1128\/MCB.00705-08","volume":"29","author":"T Yoshizaki","year":"2009","unstructured":"Yoshizaki T, Milne JC, Imamura T et al (2009) SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 29:1363\u20131374","journal-title":"Mol Cell Biol"},{"key":"4053_CR32","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMra1100831","volume":"364","author":"L Guarente","year":"2011","unstructured":"Guarente L (2011) Franklin H. Epstein lecture. Sirtuins, aging, and medicine. N Engl J Med 364:2235\u20132244","journal-title":"N Engl J Med"},{"key":"4053_CR33","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.2353\/ajpath.2009.090138","volume":"175","author":"M Torreggiani","year":"2009","unstructured":"Torreggiani M, Liu H, Wu J et al (2009) Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. Am J Pathol 175:1722\u20131732","journal-title":"Am J Pathol"},{"key":"4053_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1172\/JCI29709","volume":"117","author":"Y Takemura","year":"2007","unstructured":"Takemura Y, Ouchi N, Shibata R et al (2007) Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest 117:375\u2013386","journal-title":"J Clin Invest"},{"key":"4053_CR35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2337\/db09-1187","volume":"59","author":"SV de Kreutzenberg","year":"2010","unstructured":"de Kreutzenberg SV, Ceolotto G, Papparella I et al (2010) Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59:1006\u20131015","journal-title":"Diabetes"},{"key":"4053_CR36","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1074\/jbc.M110.144097","volume":"286","author":"O Brouwers","year":"2011","unstructured":"Brouwers O, Niessen PM, Ferreira I et al (2011) Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. J Biol Chem 286:1374\u20131380","journal-title":"J Biol Chem"},{"key":"4053_CR37","first-page":"6634","volume":"90","author":"R Bucala","year":"1993","unstructured":"Bucala R, Makita Z, Koschinsky T et al (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A 90:6634\u20136638","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4053_CR38","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.foodchem.2015.06.049","volume":"190","author":"JL Scheijen","year":"2016","unstructured":"Scheijen JL, Clevers E, Engelen L et al (2016) Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: presentation of a dietary AGE database. Food Chem 190:1145\u20131150","journal-title":"Food Chem"},{"key":"4053_CR39","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462\u20131470","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4053-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-016-4053-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4053-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:56:46Z","timestamp":1656896206000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-016-4053-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["4053"],"URL":"https:\/\/doi.org\/10.1007\/s00125-016-4053-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]},"assertion":[{"value":"10 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by the National Institutes of Health (grant DK091231 to HV) and by the National Institute of Research Resources (grant MO1-RR-00071 to the General Clinical Research Center at Mount Sinai School of Medicine) for clinical and statistical support.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"HV designed the study, interpreted the data, and wrote, reviewed and edited the manuscript. WC participated in the experimental design, the acquisition and interpretation of data, and reviewed the manuscript. ET, the study dietitian, participated in the design of the dietary protocol and the interpretation of nutritional data, and reviewed the manuscript. RP, the study coordinator, participated in the design of the clinical protocol and the acquisition and interpretation of clinical data, and reviewed the manuscript. KY, the study coordinator, participated in the design of the clinical protocol and the acquisition of clinical data, and reviewed manuscript. LG, the study dietitian, participated in the design of the dietary protocol and the acquisition of nutritional data, and reviewed and edited the manuscript. LT, a study dietitian, participated in the design of the dietary protocol and the acquisition and interpretation of nutritional data, and reviewed and edited the manuscript. XC participated in the experimental design and the acquisition of data, and reviewed and edited the manuscript. VM participated in the study design and performance and in the interpretation of data from MRI studies, and edited the final manuscript. ZAF participated in the original study design and performance and in the interpretation of data from MRI studies, and edited the final manuscript. GN participated in the study design and in all the statistical analyses, and reviewed and edited the manuscript. GES participated in the study design and interpretation of data, and reviewed and edited the manuscript. JCH participated in the study design and interpretation of data and reviewed the final manuscript. JU participated in the design of the study, the acquisition and interpretation of data and in the statistical analyses, and reviewed and edited the manuscript. JU and HV are the guarantors of this work. All authors have revised the final updated version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}